首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

1623036

全球臍帶血銀行市場規模（按銀行類型、應用程式、最終用戶、地區、範圍和預測）

Global Cord Blood Banking Market Size By Bank Type (Private, Public, Hybrid), By Application (Hematological Malignancies, Non-Malignant Diseases, Regenerative Medicine), By End-User (Hospitals, Research Institutes), By Geographic Scope And Forecast

出版日期: 2024年08月27日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

臍帶血庫市場的規模及預測

臍帶血庫市場規模預計在 2023 年達到 20.5 億美元，到 2031 年將達到 66.7 億美元，2024 年至 2031 年的複合年增長率為 14%。臍帶血庫是收集臍帶血、提取幹細胞和其他免疫系統細胞並冷凍保存以備將來醫療使用的過程。出生後殘留在臍帶和胎盤的血液稱為臍帶血。母胎細胞移植是在足月或接近足月時進行的，以增強母親和嬰兒的免疫系統，為出生做準備。

臍帶血含有大量幹細胞，可治療80多種遺傳疾病。這些疾病包括癌症、血液疾病、糖尿病和免疫系統疾病，都可以用臍帶血幹細胞治療。

由於治療應用的進步、新興市場的尚未開發的機會以及提高認識的努力，全球臍帶血銀行市場預計將擴大。

全球臍帶血銀行市場動態

影響全球臍帶血銀行市場的關鍵市場動態

主要市場驅動因子

提高正念：

準父母逐漸意識到臍帶血庫的好處，例如其能夠治療各種疾病和問題，對臍帶血庫的興趣也日益增加。

臨床測試的進展：

臨床研究的不斷進步，特別是在再生醫學和基礎微生物治療領域，正在擴大臍帶血未分化生物的預期應用，從而增加人們對臍帶血庫的興趣。

進展性疾病增加：

白血病、淋巴瘤和遺傳性疾病等慢性病的發生率不斷上升，促使先進療法，尤其是基因療法的應用激增，以支持臍帶血療效領域的持續研究和開發。因此，對臍帶血益處的認識和研究支持的提高促進了各個地區採用臍帶血庫。

政府推動與支持：

政府支持未分化細胞測試和移植的舉措和指導方針以及公共臍帶血捐贈中心的建立，正在透過提高臍帶血銀行市場的關注度和可用性來幫助該市場的發展。

機械式進步：

臍帶血處理、儲存和移植程序的創新進步正在提高臍帶血未分化生物的合理性和生存能力，使臍帶血庫成為父母和醫療保健提供者更具吸引力的選擇。

擴大醫療消費：

醫療保健利用率的提高和對醫療保健基礎設施日益增長的興趣（尤其是在新興經濟體中）正在推動臍帶血庫的接受度並支持其發展。

主要問題：

有限的正念：

儘管臍帶血銀行有許多好處，但準父母對臍帶血和組織保存重要性的認識仍然有限。人們正在越來越多地認識到臍帶血的潛在修復用途。

大筆開支：

管理臍帶血庫的成本可能非常高，包括初始處理和儲存費用以及持續的維護費用。臍帶血庫的高昂費用可能會阻止一些家庭考慮它作為一種選擇，特別是在醫療保健對某些人沒有保障或限制的地區。

道德問題

臍帶血庫的商業化引發了道德問題，特別是有關臍帶血的使用問題。由於文化的限制，未來幾年臍帶血庫的採用率可能會下降。

管理困難：

在許多國家，臍帶血庫依賴政府監督，遵守政府要求可能是一項艱鉅的任務。確保臍帶血單位的選擇、處理、儲存和傳播方面的指導方針的一致性，對市場提出了深思熟慮和權威的課題。

容量限制：

臍帶血庫單位的生產能力有限，無法滿足每年日益增長的臍帶血採集數量。隨著容量限制的出現，丟棄的臍帶血單位數量將會增加，因此需要對框架開發和技術創新產生興趣。

主要趨勢：

提高認識與接受度：

孕婦越來越意識到臍帶血庫的好處，包括使用臍帶血幹細胞治療各種疾病和病症的可能性。這種日益增長的認識和接受度正在推動全球對臍帶血銀行服務的需求。

技術進步：

技術的進步，包括幹細胞分離、處理和冷凍保存技術的改進，正在提高儲存臍帶血的品質和活力。這些技術進步使得臍帶血庫更有效可靠，吸引了更多的客戶。

擴大公共臍帶血庫：

公共臍帶血庫在提供用於移植和研究目的的臍帶血幹細胞方面發揮越來越重要的作用。政府和醫療保健組織正在投資擴大公共臍帶血庫基礎設施，以便為有需要的患者提供更多多樣化、高品質的臍帶血。

Cord Blood Banking Market size is valued at USD 2.05 Billion in 2023 and is projected to reach USD 6.67 Billion by 2031, growing at a CAGR of 14% from 2024 to 2031. Cord blood banking is the process of taking cord blood, extracting its stem cells and other immune system cells, and cryogenically storing them for future medical use. The blood that stays in the umbilical cord and placenta after birth is known as cord blood (short for umbilical cord blood). A maternal-fetal cell transfer occurs at or near term to enhance the immune systems of both the mother and the baby in preparation for childbirth.

Cord blood includes a large number of stem cells that can be used to cure over 80 hereditary illnesses. These illnesses include cancer, blood illnesses, diabetes, and immunological diseases, all of which can be treated with cord blood stem cells.

The Global Cord Blood Banking Market is expected to rise due to advancements in therapeutic application, untapped opportunities in developing regions, and initiatives to spread awareness.

Global Cord Blood Banking Market Dynamics

The key market dynamics that are shaping the global Cord Blood Banking Market include:

Key Market Drivers:

Increasing Mindfulness:

Developing mindfulness among eager guardians about the advantages of cord blood banking, for example, its capability to treat different sicknesses and problems, is driving interest for cord blood banking administrations.

Progressions in Clinical Exploration:

Continuous headways in clinical examination, especially in regenerative medication and foundational microorganism treatment, are extending the expected uses of line blood undifferentiated organisms, consequently driving the interest for cord blood banking.

Rising Commonness of Ongoing Diseases:

The rising predominance of persistent sicknesses like leukemia, lymphoma, and hereditary issues is surging the application of advanced treatments, especially genetic-based therapies, to support the ongoing research and development in the field of effectiveness of cord bloods. Thus, the growing awareness regarding the benefits of cord blood and supporting research are driving the adoption of cord blood banking across diverse regions.

Government Drives and Backing:

Government drives and guidelines supporting undifferentiated cell examination and transplantation, alongside the foundation of public cord blood donation centers, are helping the development of the Cord Blood Banking Market by advancing mindfulness and availability.

Mechanical Progressions:

Innovative headways in cord blood handling, stockpiling, and transplantation procedures have worked on the reasonability and viability of line blood undifferentiated organisms, making cord blood banking a more alluring choice for guardians and medical services suppliers.

Expanding Medical Care Consumption:

Rising medical care use and interests in medical care foundation, especially in arising economies, are driving the reception of cord blood banking administrations and supporting the progression of this business.

Key Challenges:

Restricted Mindfulness:

Despite the likely advantages of cord blood banking, there is as yet restricted mindfulness among hopeful guardians about the significance of cord blood and tissue protection. Growing awareness about its potential restorative applications stays a test.

Significant Expense:

Cord blood banking administrations can be exorbitant, including introductory handling and stockpiling charges along with progressing upkeep charges. The significant expense of string blood banking might dissuade a few families from considering it as a choice, especially in districts where medical care costs are not covered by protection or are restrictive for some.

Moral Worries:

There are moral contemplations surrounding the commercialization of cord blood banking, especially the ethical issues concerning the use of cord blood. The cultural restrictions are likely to decrease its adoption in the coming years.

Administrative Difficulties:

Cord blood banking is dependent upon administrative oversight in numerous nations, and consistence with administrative necessities can be mind boggling and tedious. Guaranteeing consistence with guidelines for assortment, handling, stockpiling, and dissemination of cord blood units presents calculated and authoritative difficulties for the market.

Capacity Limits:

The capacity limitations of cord blood banking units is unable to meet the increasing number of cord blood gathered every year. As the capacity constraints emerge, the volume of discarded cord blood units increments, thereby requiring interests in framework development and innovation.

Key Trends:

Increasing Awareness and Acceptance:

There is growing awareness among expectant parents about the benefits of cord blood banking, such as the potential to treat various diseases and conditions using stem cells derived from cord blood. This increased awareness and acceptance are driving demand for cord blood banking services globally.

Technological Advancements:

Advances in technology, including improvements in stem cell isolation, processing, and cryopreservation techniques, are enhancing the quality and viability of stored cord blood units. These technological advancements are making cord blood banking more effective and reliable, thus attracting more customers.

Expansion of Public Cord Blood Banks:

Public cord blood banks are playing an increasingly important role in providing access to cord blood stem cells for transplantation and research purposes. Governments and healthcare organizations are investing in the expansion of public cord blood banking infrastructure to increase the availability of diverse and high-quality cord blood units for patients in need.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cord Blood Banking Market Regional Analysis

Here is a more detailed regional analysis of the global Cord Blood Banking Market:

North America:

North America has a well-established healthcare system and a high degree of knowledge among pregnant parents about the benefits of cord blood banking. As a result, the region has a higher adoption rate of cord blood banking services than other parts of the world, enabling the region dominate the market.

The regulatory frameworks governing cord blood banking in North America are well-established and supportive public and private banks. Regulatory authorities, such as the FDA (Food and Drug Administration) in the United States, establish standards and oversight to ensure cord blood banking techniques are safe and effective.

The region is at the forefront of scientific developments in healthcare, such as stem cell research and biotechnology. This technological skill allows North American cord blood banks to offer state-of-the-art storage and processing facilities, enhancing the quality and viability of stored cord blood units.

Asia Pacific:

Asia Pacific has a huge and quickly growing population, with countries such as China, India, and Southeast Asian nations seeing rise in birth rates. This demographic trend is generating demand for cord blood banking services as more parents learn about the benefits of keeping cord blood for future medical use.

Rising disposable incomes and growing middle-class populations in Asia Pacific countries are driving up spending on healthcare services, especially prenatal and neonatal care. This rising healthcare spending is fueling demand for innovative medical technologies, such as cord blood banking, to protect the health and well-being of newborns and pregnant women.

Healthcare professionals, patient advocacy groups, and educational institutions throughout Asia Pacific are raising awareness about the medicinal potential of cord blood stem cells.

Global Cord Blood Banking Market: Segmentation Analysis

The Global Cord Blood Banking Market is segmented on the basis of Bank Type, Application, End-User, And Geography.

Cord Blood Banking Market, By Bank Type

Private
Public
Hybrid

Based on Bank Type, The market is segmented into Private, Public, and Hybrid. The private cord blood banking segment holds the largest market share, accounting for approximately 80% of the global market revenue. On the other hand, the public cord blood banking segment is expected to grow at a faster rate in the coming years due to increasing government support for public cord blood banking programs and growing awareness of the ethical implications of private cord blood banking.

Cord Blood Banking Market, By Application

Hematological Malignancies
Non-Malignant Diseases
Regenerative Medicine

Based on Application, The market is segmented into Hematological Malignancies, Non-Malignant Diseases, and Regenerative Medicine. The hematological malignancies is expected to dominate the global Cord Blood Banking Market over the forecast timeframe. Growing presence of cancer is surging the need for cord blood banking for effective treatment, thereby enabling this segment retain its top position. While other applications such as non-malignant diseases and regenerative medicine is anticipated to be promising, their widespread adoption in the clinical sector is still in its early stages.

Cord Blood Banking Market, By End-User

Hospitals
Research Institutes
Others

Based on End-User, The market is segmented into Hospitals, Research Institutes, and Others. As per our analyst, hospitals segment is estimated to hold large share in the market. Increasing child birth in hospitals acts a primary point of contact in facilitating cord blood collection. Also, the availability of well-equipped infrastructure and healthcare professionals to safely collect, process, and store cord blood samples for potential future use will help hospitals keep contact with well-known cord blood banking.

Key Players

The " Global Cord Blood Banking Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are
Lifeforce Cryobanks, China Cord Blood Corporation, Cordlife Group, Virgin Health Bank, Cord Blood America, CBR Systems, Cryo-Cell International, ViaCord, National Cord Blood Program, Americord, StemCyte, Cryo-Save Group, NeoStem, and Blood Centers of America.

Our market analysis includes a section specifically devoted to such major players, where our analysts give an overview of each player's financial statements, along with product benchmarking and SWOT analysis. Key development strategies, market share analysis, and market positioning analysis of the aforementioned players globally are also included in the competitive landscape section.

Cord Blood Banking Market Recent Developments
In May 2021, SingHealth Duke-NUS Academic Medical Centre and Cordlife announced their partnership. This strategy will benefit the company in developing new technologies related to stem cell and blood therapies and increase its share in the industry.
In August 2019, Cordlife announced its geographical expansion into Bangladesh. This strategy benefited the company to expand its geographical footprint and acquired a larger market share.
In January 2024, DKMS Chile launched first collection center in Santiago de Chile to enhance stem cell collection as well as transplant capacity in the country and improve access to treatment for patients in need.

1 INTRODUCTION TO THE GLOBAL CORD BLOOD BANKING MARKET

1.1 Introduction of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CORD BLOOD BANKING MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL CORD BLOOD BANKING MARKET, BY BANK TYPE

5.1 Overview
5.2 Private
5.3 Public
5.4 Hybrid

6 GLOBAL CORD BLOOD BANKING MARKET, BY APPLICATION

6.1 Overview
6.2 Hematological Malignancies
6.3 Non-Malignant Diseases
6.4 Regenerative Medicine

7 GLOBAL CORD BLOOD BANKING MARKET, BY END-USER

7.1 Overview
7.2 Hospitals
7.3 Research Institutes
7.4 Others

8 GLOBAL CORD BLOOD BANKING MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 The U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 The U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL CORD BLOOD BANKING MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Lifeforce Cryobanks
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 China Cord Blood Corporation
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Cordlife Group
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Virgin Health Bank
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Cord Blood America
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 CBR Systems
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Cryo-Cell International
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 ViaCord
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 National Cord Blood Program
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Americord
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments